| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/07/2008 | EP1918287A2 LPA receptor agonists and antagonists and methods of use |
| 05/07/2008 | EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain |
| 05/07/2008 | EP1918278A1 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases |
| 05/07/2008 | EP1917978A1 Premature ovulation preventive agent |
| 05/07/2008 | EP1917961A1 Capsinoid containing composition |
| 05/07/2008 | EP1917958A2 Improved HIV protease inhibitors pharmaceutical formulations |
| 05/07/2008 | EP1483285B1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME |
| 05/07/2008 | EP1480951B1 Synthesis of indole thiazole compounds as ligands for the ah receptor |
| 05/07/2008 | EP1467757B1 Use of antibodies against the muc18 antigen |
| 05/07/2008 | EP1460969B1 Prevention and treatment of androgen-deprivation induced osteoporosis |
| 05/07/2008 | EP1456651B1 Self-assembly molecules |
| 05/07/2008 | EP1434792B1 Peptidyl ketones as inhibitors of dpiv |
| 05/07/2008 | EP1411984B1 Combination medicament for treatment of neoplastic diseases which contains cyanoguanidine ikk inhibitors and a second anti-neoplastic drug |
| 05/07/2008 | EP1405848B1 Tetrahydroquinoline derivative compound and drug containing the compound as active ingredient |
| 05/07/2008 | EP1390347B1 Pyrrolidine ester derivatives with oxytocin modulating activity |
| 05/07/2008 | EP1385531B1 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation |
| 05/07/2008 | EP1383774B1 Dihydroimidazo¬4,5-e indole and 7h-pyrrolo¬3,2-f quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 05/07/2008 | EP1380593B1 Soluble rage protein |
| 05/07/2008 | EP1356036B1 Process and compositions for peptide, protein and peptidomimetic synthesis |
| 05/07/2008 | EP1299381B1 Substituted quinazoline derivatives and their use as inhibitors |
| 05/07/2008 | EP1250325B1 Phenanthridine-n-oxides |
| 05/07/2008 | EP1059929B1 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 05/07/2008 | EP0991758B1 Smad6 and uses thereof |
| 05/07/2008 | EP0956299B1 Peptide antagonists of dp transcription factors |
| 05/07/2008 | CN101172983A Substituted phenylacetic acids |
| 05/07/2008 | CN101172980A Method for the preparation of hexahydro-furo 2,3-b furan-3-ol |
| 05/07/2008 | CN101172977A Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications |
| 05/07/2008 | CN101172116A Composition, preparing method and application of the same |
| 05/07/2008 | CN101171965A Use of boraginaceae cynoglossum plants in producing health food |
| 05/07/2008 | CN100386339C Fatty acid derivatives of bile acids and bile acid derivatives |
| 05/07/2008 | CN100386329C Substituted 3-amino-thieno(2,3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 05/07/2008 | CN100386328C Bicyclic pyridine and pyrimidine P38 kinase inhibitors |
| 05/07/2008 | CN100386116C Sustained release of microcrystalline peptide suspensions |
| 05/07/2008 | CN100386075C Medicine capable of promoting height elevation and formulation thereof |
| 05/06/2008 | US7368578 superior in an adipose tissue weight decreasing action and a retinoid-related receptor function regulating action; to treat obesity, diabetes mellitus, hyperlipidemia, impaired glucose tolerance, hypertension; fewer side effects; 4-{[2-(2-furyl)-1,3-oxazol-4-yl]methoxy}-3-methoxybenzaldehyde |
| 05/06/2008 | US7368575 Chronic inflammation, rheumatoid arthritis, colitis, asthma and psoriasis; solid phase synthetic methods to efficiently construct numerous drug-like libraries |
| 05/06/2008 | US7368553 nucleotide sequences comprising cDNA and genomic DNA that code for angiogenesis factors, used for gene therapy |
| 05/06/2008 | US7368545 PCA3 messenger RNA species in benign and malignant prostate tissues |
| 05/06/2008 | US7368530 Human intestinal Npt2B |
| 05/06/2008 | US7368471 fibrinolytic disorders such as deep vein thrombosis and coronary heart disease, and pulmonary fibrosis, Alzheimer's disease; {1-Methyl-6-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid |
| 05/06/2008 | US7368465 Metalloproteinase inhibitors |
| 05/06/2008 | US7368459 Heterocyclic compounds |
| 05/06/2008 | US7368444 4-Hydroxy-1-toluenesulfonyl-2,3,4,5-tetrahydro-1H-1-benzazepine, for example; useful as the preventive and/or treatment medicine against diseases caused by stress |
| 05/06/2008 | US7368440 Methods for the administration of amifostine and related compounds |
| 05/06/2008 | US7368436 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 05/06/2008 | US7368431 Polypeptide, the conjugate thereof with doxorubicine and a pharmaceutical composition based thereon |
| 05/06/2008 | US7368423 Composition and method for treating chronic allograft rejection |
| 05/06/2008 | US7368287 For treatment and/or prevention of inflammation and autoimmune disease; vaccines |
| 05/06/2008 | US7368270 Polynucleotide encoding polypeptide having phosphatidylserine-specific activity; lipid metabolism enzymes used in diagnosis, treatment, and prevention of cancer, neurological, autoimmune/inflammatory, gastrointestinal and cardiovascular disorders |
| 05/06/2008 | US7368254 Lipid-based systems for targeting diagnostic agents |
| 05/06/2008 | US7368244 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics |
| 05/06/2008 | US7368104 Glycopyrrolate in sustained releae form; antimuscarinic agents |
| 05/06/2008 | US7368098 Use of biomolecular targets in the treatment and visualization of tumors |
| 05/06/2008 | CA2440331C Atorvastatin calcium in a pharmaceutical form, composition thereof, and pharmaceutical formulation comprising atorvastatin calcium |
| 05/06/2008 | CA2430601C Piperazine derivatives |
| 05/06/2008 | CA2397767C Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 05/06/2008 | CA2390649C 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them |
| 05/06/2008 | CA2377803C Phenyl sulfamate derivatives |
| 05/06/2008 | CA2345675C Two chamber cartridge for atomizers |
| 05/06/2008 | CA2322229C Compositions comprising heparin and soluble tnf receptors for inhibition of tnf activity |
| 05/06/2008 | CA2294352C Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6] cyclohepta[1,2-b]pyridine |
| 05/06/2008 | CA2280727C Bicyclic amino acids |
| 05/02/2008 | WO2008051505A2 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 05/02/2008 | WO2008051502A1 Purine derivatives for the treatment of cystic diseases |
| 05/02/2008 | WO2008050910A1 Grifola frondosa-origin substance having antiinfluenza virus activity and method of producing the same |
| 05/02/2008 | WO2008050898A1 PARTIAL FRAGMENT OF REIC/Dkk-3 GENE AND THERAPEUTIC AGENT FOR CANCER CONTAINING THE SAME |
| 05/02/2008 | WO2008050866A1 Preparation containing highly purified botulinum toxin type a derived from infant botulism pathogen |
| 05/02/2008 | WO2008050857A1 Amide compound or salt thereof, and biofilm formation inhibitor, biofilm remover and bactericide each using the amide compound or salt thereof |
| 05/02/2008 | WO2008050855A1 Gene sensitive to bone/joint disease and use thereof |
| 05/02/2008 | WO2008050853A1 Therapeutic agents for irritable bowel syndrome |
| 05/02/2008 | WO2008050836A1 Agent for ameliorating adverse side-effect of chemotherapeutic agent |
| 05/02/2008 | WO2008050808A1 2-aminoquinazoline derivative |
| 05/02/2008 | WO2008050732A1 Iminopyridine derivative and use thereof |
| 05/02/2008 | WO2008050707A1 Pharmaceutical agent and extract for use in the pharmaceutical |
| 05/02/2008 | WO2008050600A1 Therapeutic or preventive agent for intractable disease based on oxidative stress-mediated cell death as molecular background |
| 05/02/2008 | WO2008050483A1 Cardiovascular preparation |
| 05/02/2008 | WO2008050207A1 Heterocyclic compounds useful as anabolic agents for livestock animals |
| 05/02/2008 | WO2008049281A1 Construction method of hepatic tissue engineering construct and the hepatic tissue engineering construct |
| 05/02/2008 | WO2008028977A3 Serum albumin binding proteins with long half-lives |
| 05/02/2008 | CA2667536A1 Highly purified type a botulinum toxin preparation from infant botulism pathogen |
| 05/02/2008 | CA2667280A1 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage |
| 05/02/2008 | CA2667176A1 Therapeutic agent for irritable bowel syndrome |
| 05/01/2008 | US20080103206 Synergistic analgesics, antipyretics, and non-steroidal antiinflammatory agents; other oral dosage forms may include a third analgesic; side effect reduction |
| 05/01/2008 | US20080103204 Upregulating or downregulating microglial cells which synthesize nitric oxide; 2-[[3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl]amino]benzoic acid; Parkinson's, Alzheimer's Diseases, AIDS |
| 05/01/2008 | US20080103199 2chlorophenyl-2hydroethyl-carbomate; Autistic, Asperger's, Childhood Disintegrative, Rett's Disorders, and PDD-Not Otherwise Specified; sensory integration problems, (non) verbal communication, social interactions; improve impulse control; inhibit isolation-induced aggressive behavior; co-therapy |
| 05/01/2008 | US20080103187 Reaction product of N-methylpyrrole, N-methylimidazole, 4-aminobutyric acid and B-alanine that can be folded into a U-shaped conformation at the gamma -aminobutyrate unit in a minor groove of a double helix region; conjugates with fluorescein isothiocyanate; antiproliferative agents; restenosis |
| 05/01/2008 | US20080103184 Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| 05/01/2008 | US20080103180 CCR9 inhibitors and methods of use thereof |
| 05/01/2008 | US20080103179 For treating diabetes, hypertension, migraine, epilepsy, sleep apnea, depression, impulse control disorders or alcohol addiction; coadministering a sympathomimetic agent such as phentermine and an anticonvulsant sulfamate or sulfonylurea, preferably topiramate or zonisamide; side effect reduction |
| 05/01/2008 | US20080103166 Administering tropisetron to prevent and treat Schizophrenia, Alzheimer's, Parkinson's, and Huntington's Diseases,Tourette's Syndrome and Attention deficit disorder; antidepressants, anxiolytic and antiepileptic agents |
| 05/01/2008 | US20080103152 7-{4-[3-(2-chloro-3,6-difluorophenoxy)propyl]phenyl}-3,9-diazabicyclo [3.3.1]non-6-ene-6-carboxylic acid cyclopropyl-(2,3-dichlorobenzyl)amide; renin inhibitor; hypotensive agent, renal and cardial diseases, antidiabetic, antiinflammatory, anxiolitic agent, antidepressant |
| 05/01/2008 | US20080103150 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level |
| 05/01/2008 | US20080103148 Preventing ventilator induced pneumonia; utilizing compounds having longer half life on mucosal surfaces |
| 05/01/2008 | US20080103147 Highly selective norepinephrine reuptake inhibitors and methods of using the same |
| 05/01/2008 | US20080103146 Highly Selective Norepinephrine Reuptake Inhibitors And Methods Of Using The Same |
| 05/01/2008 | US20080103145 Administering racemic reboxetine component |
| 05/01/2008 | US20080103140 Cyclohexylamides as Dopamine D3, D2 and 5Ht1a Antagonists |
| 05/01/2008 | US20080103137 antiinflammatory agents; 1H-imidazo[4,5-b]pyridin-7-indole-2-yl- derivatives; autoimmune and proliferative disorders; inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction; rheumatoid arthritis, ulcerative colitis/Crohn's disease, central nervous system diseases |
| 05/01/2008 | US20080103130 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality |
| 05/01/2008 | US20080103126 2-[[3-(2-benzo[b]thiophen-5-yl-ethoxy)propyl](methyl)amino]-1-ethanol; antihypoxic agent; synergistic mixture with acetylcholine esterase inhibitor (Tacrine, Donepezil, Rivastigmine); neurodegenerative diseases, ischemic cerebral lesion, cerebral apoplexy, Alzheimer's disease, cognition activator |